Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Ziltivekimab Biosimilar -­ Research Grade Hu FA CHO cells ICH6008-1mg

IchorBio
1 mg Login
Compare
Ziltivekimab Biosimilar -­ Research Grade Hu FA CHO cells ICH6008-25mg

IchorBio
25 mg Login
Compare
Ziltivekimab Biosimilar -­ Research Grade Hu FA CHO cells ICH6008-50mg

IchorBio
50 mg Login
Compare
Ziltivekimab Biosimilar -­ Research Grade Hu FA CHO cells ICH6008-5mg

IchorBio
5 mg Login
Compare
Zuberitamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6012-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Zuberitamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6012-1mg

IchorBio
1 mg Login
Compare
Zuberitamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6012-25mg

IchorBio
25 mg Login
Compare
Zuberitamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6012-50mg

IchorBio
50 mg Login
Compare
Zuberitamab Biosimilar -­ Research Grade Hu FA CHO cells ICH6012-5mg

IchorBio
5 mg Login
Compare
Sonesitatug Biosimilar -­ Research Grade Hu FA CHO cells ICH6017-100mg

IchorBio
100 mg Login
Compare
Suciraslimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5884-25mg

IchorBio
25 mg Login
Compare
Suciraslimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5884-50mg

IchorBio
50 mg Login
Compare
Suciraslimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5884-5mg

IchorBio
5 mg Login
Compare
Suvemcitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5889-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Suvemcitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5889-1mg

IchorBio
1 mg Login
Compare
Suvemcitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5889-25mg

IchorBio
25 mg Login
Compare
Suvemcitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5889-50mg

IchorBio
50 mg Login
Compare
Suvemcitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5889-5mg

IchorBio
5 mg Login
Compare
Tabituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5892-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Tabituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5892-1mg

IchorBio
1 mg Login
Compare
Tabituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5892-25mg

IchorBio
25 mg Login
Compare
Tabituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5892-50mg

IchorBio
50 mg Login
Compare
Tabituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5892-5mg

IchorBio
5 mg Login
Compare
Talacotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5896-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Talacotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5896-1mg

IchorBio
1 mg Login
Compare
Name Price
Ziltivekimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Ziltivekimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Ziltivekimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Ziltivekimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Zuberitamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Zuberitamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Zuberitamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Zuberitamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Zuberitamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sonesitatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 100 mg
Available
Suciraslimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Suciraslimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Suciraslimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Suvemcitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Suvemcitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Suvemcitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Suvemcitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Suvemcitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Tabituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Tabituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Tabituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tabituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tabituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Talacotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Talacotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available

2719 Item(s)

per page